Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Mindbio Therapeutics Corp. ( (TSE:MBIO) ).
MindBio Therapeutics Corp. has launched Booze AI, the world’s first AI-driven, voice-activated blood alcohol concentration estimator, in Silicon Valley. This innovative app uses machine learning to analyze speech patterns and estimate alcohol levels, aiming to promote responsible drinking and prevent impaired driving. The app’s launch represents a significant advancement in alcohol safety technology, offering a user-friendly tool for intoxication detection and harm reduction, and is available for download with a discount.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a clinical-stage biopharmaceutical and biotechnology company. It focuses on developing innovative solutions in the mental health sector, leveraging its research on the effects of drugs and alcohol on speech patterns to create new technologies.
Average Trading Volume: 143,361
Technical Sentiment Signal: Sell
For detailed information about MBIO stock, go to TipRanks’ Stock Analysis page.